Profile data is unavailable for this security.
About the company
Iconovo AB is a Sweden-based company, which offers inhalation solutions for pharmaceutical companies. Solutions are based on the Company’s device platforms and include formulation, analytical testing and documentation. Iconovo Ab develops products, which are a part of device family and include: ICOres, reservoir devices, ICOone, disposable unit-dose devices, ICOcap, capsule-based devices and ICOpre, pre-metered devices. Moreover, the Company offers programs, which include development of generic inhalation products, where the products are registered based on therapeutic equivalence; development of inhalation products based on a generic application programming interface (API) and new chemical entity (NCE); as well as phase I-II clinical trials using ICOone.
- Revenue in SEK (TTM)8.47m
- Net income in SEK-42.40m
- Incorporated2013
- Employees29.00
- LocationIconovo ABIdeon, Delta 6, Ideongatan 3BLUND 223 81SwedenSWE
- Phone+46 462756777
- Websitehttps://www.iconovo.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Luxbright AB | 952.90k | -25.38m | 93.14m | 10.00 | -- | 2.76 | -- | 97.74 | -0.2752 | -0.2752 | 0.0103 | 0.3653 | 0.0265 | -- | 1.99 | 95,290.00 | -70.61 | -61.39 | -81.90 | -70.36 | -947.28 | -559.15 | -2,662.94 | -2,459.34 | -- | -1,722.29 | 0.0061 | -- | 73.46 | -- | -20.07 | -- | -- | -- |
| Observe Medical ASA | 27.52m | -59.46m | 97.67m | 12.00 | -- | 0.8577 | -- | 3.55 | -1.05 | -1.05 | 0.4849 | 0.6063 | 0.1191 | 2.49 | 7.12 | 2,328,500.00 | -25.72 | -32.60 | -35.90 | -49.80 | 33.24 | 32.83 | -216.03 | -256.25 | 0.334 | -6.01 | 0.3204 | -- | 43.14 | 204.81 | -18.82 | -- | 32.69 | -- |
| BBS-Bioactive Bone Substitutes Oyj | 0.00 | -39.67m | 101.69m | -- | -- | 1.66 | -- | -- | -0.2926 | -0.2926 | 0.00 | 0.2647 | 0.00 | -- | -- | -- | -32.71 | -25.12 | -38.23 | -28.54 | -- | -- | -- | -- | -- | -28.79 | 0.482 | -- | -- | -- | -12.64 | -- | -- | -- |
| ScandiDos AB | 65.08m | -4.85m | 102.62m | 34.00 | -- | 2.37 | -- | 1.58 | -0.1063 | -0.1063 | 1.43 | 0.7588 | 0.9573 | 0.4787 | 7.39 | -- | -7.14 | -13.82 | -13.39 | -23.95 | 82.54 | 82.49 | -7.45 | -17.09 | 0.4511 | -2.63 | 0.00 | -- | 6.70 | 4.01 | -24.27 | -- | 4.18 | -- |
| Redsense Medical AB (publ) | 19.85m | -7.57m | 106.99m | 5.00 | -- | 5.38 | -- | 5.39 | -0.5389 | -0.5389 | 1.41 | 1.42 | 0.7261 | 4.51 | 5.02 | 3,970,800.00 | -27.67 | -18.66 | -31.75 | -20.99 | 50.11 | 69.02 | -38.11 | -46.28 | 2.21 | -- | 0.00 | -- | 74.11 | 28.94 | 48.47 | -- | -23.62 | -- |
| Nanexa AB | 28.91m | -70.62m | 124.84m | 19.00 | -- | 1.34 | -- | 4.32 | -0.8143 | -0.8143 | 0.3252 | 0.6854 | 0.2069 | -33.45 | 2.26 | 1,521,474.00 | -50.54 | -40.77 | -66.82 | -48.77 | 124.70 | 77.27 | -244.28 | -532.26 | 2.14 | -- | 0.0193 | -- | 925.42 | 147.00 | -30.44 | -- | 39.10 | -- |
| Dignitana AB | 85.74m | -18.48m | 130.48m | 28.00 | -- | 42.16 | -- | 1.52 | -0.2487 | -0.2487 | 1.15 | 0.0384 | 1.66 | 3.35 | 14.61 | 3,175,519.00 | -35.81 | -42.21 | -97.80 | -68.91 | 69.11 | 66.09 | -21.55 | -57.29 | 0.3234 | -8.84 | 0.8571 | -- | 17.90 | 20.59 | 22.52 | -- | -15.31 | -- |
| Ortivus AB | 78.15m | -20.63m | 134.23m | 42.00 | -- | 8.45 | -- | 1.72 | -0.4655 | -0.4655 | 1.76 | 0.3529 | 1.00 | 3.36 | 4.76 | 1,953,650.00 | -26.44 | -2.41 | -51.70 | -4.63 | 33.88 | 42.46 | -26.39 | -1.77 | 0.5256 | -- | 0.4544 | -- | -19.55 | 10.00 | -409.66 | -- | 67.43 | -- |
| Neola Medical AB | 0.00 | -9.04m | 168.36m | 7.00 | -- | 2.20 | -- | -- | -0.1536 | -0.1536 | 0.00 | 1.09 | 0.00 | -- | -- | 0.00 | -11.63 | -17.04 | -12.52 | -18.46 | -- | 4,237.20 | -- | -5,258.78 | -- | -- | 0.00 | -- | -- | -- | 12.97 | -- | 55.46 | -- |
| Iconovo AB | 8.47m | -42.40m | 168.73m | 29.00 | -- | 1.25 | -- | 19.92 | -3.68 | -3.68 | 0.703 | 8.45 | 0.0554 | -- | 1.24 | 292,079.00 | -27.74 | -25.43 | -30.85 | -28.24 | 234.21 | 134.57 | -500.63 | -215.16 | -- | -- | 0.0666 | -- | -58.65 | -9.88 | 4.71 | -- | 34.70 | -- |
| BibbInstruments AB | 0.00 | -11.44m | 172.44m | -- | -- | 6.10 | -- | -- | -0.4401 | -0.4401 | 0.00 | 1.06 | 0.00 | -- | -- | -- | -36.33 | -39.57 | -39.77 | -42.71 | -- | 59.36 | -- | -8,032.40 | 2.03 | -- | 0.00 | -- | -- | -- | 2.72 | -- | -1.94 | -- |
| Episurf Medical AB | 11.00m | -92.10m | 197.97m | 25.00 | -- | 1.39 | -- | 18.00 | -0.266 | -0.266 | 0.0318 | 0.1861 | 0.0852 | -- | 5.24 | 392,857.20 | -71.42 | -47.46 | -81.48 | -52.01 | -- | -- | -838.18 | -1,019.29 | 2.54 | -- | 0.068 | -- | 53.62 | 19.78 | -22.64 | -- | -0.4158 | -- |
| Arcoma AB | 171.89m | 9.40m | 206.35m | 31.00 | 21.95 | 3.91 | 12.51 | 1.20 | 0.713 | 0.713 | 13.04 | 4.01 | 1.81 | 3.71 | 6.93 | 5,544,871.00 | 9.92 | 1.12 | 18.49 | 2.01 | 36.83 | 37.66 | 5.47 | 0.7568 | 0.9788 | 11.95 | 0.0475 | 0.00 | 30.36 | 6.41 | 34.81 | -- | 22.75 | -- |
| Nexstim Oyj | 82.51m | -15.12m | 215.71m | 37.00 | -- | 6.68 | -- | 2.61 | -0.1956 | -0.1956 | 1.09 | 0.4192 | 0.7211 | 0.2708 | 3.76 | 195,845.70 | -13.21 | -26.77 | -20.24 | -43.90 | 96.38 | 92.11 | -18.32 | -38.38 | 1.42 | -12.60 | 0.61 | -- | -23.94 | 22.08 | -201.58 | -- | 19.51 | -- |
| Acousort AB | 4.29m | -17.78m | 221.03m | -- | -- | 11.06 | -- | 51.47 | -1.25 | -1.25 | 0.3048 | 1.34 | 0.1595 | 4.59 | 4.21 | -- | -66.05 | -48.62 | -99.10 | -69.77 | -117.16 | -68.05 | -414.04 | -299.58 | 2.72 | -- | 0.00 | -- | 11.51 | 38.81 | -24.01 | -- | -- | -- |
| SpectraCure AB (publ) | 2.65m | -21.06m | 250.11m | 13.00 | -- | 2.02 | -- | 94.38 | -0.2168 | -0.2168 | 0.0273 | 1.28 | 0.0178 | -- | 19.00 | 176,666.70 | -14.11 | -12.75 | -15.44 | -13.62 | 393.13 | 195.30 | -794.75 | -494.40 | -- | -- | 0.0499 | -- | -3.30 | -- | 19.46 | -- | -- | -- |
Data as of Jun 07 2024. Currency figures normalised to Iconovo AB's reporting currency: Swedish Krona SEK
11.85%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 31 Dec 2023 | 439.95k | 3.74% |
| Cicero Fonder ABas of 31 May 2024 | 400.00k | 3.40% |
| Atle Investment Services ABas of 30 Jun 2022 | 353.00k | 3.00% |
| FCG Fonder ABas of 31 Dec 2023 | 199.51k | 1.70% |
More ▼
Data from 30 Jun 2022 - 31 May 2024Source: FactSet Research Systems Inc.
